Tokyo Tape
Sign in
← AuBEX

Quarterly report · Q1

3583.TEDINET S100RMSF
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥1.3bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥5.3bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.3bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥119m2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥154m2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥135m2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥639m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥178m2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥135m2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥231m2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥110m2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥469m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥161m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥110m2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥161m2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥9.4bnat 2023-06-30Cons.Assets
Total assets¥9.3bnat 2023-03-31Cons.Assets
Total assets¥9.5bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥3.6bnat 2023-06-30Cons.Liabilities
Total liabilities¥3.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥5.9bnat 2023-06-30Cons.Net assets
Net assets / equity¥5.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥5.5bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥2.6bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥2.5bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥39.572023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥169.172022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥58.322022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio62.4%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio62.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio57.9%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue2023-04-01 → 2023-06-30¥361m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue external2023-04-01 → 2023-06-30¥361m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥323,000
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentsegment profit2023-04-01 → 2023-06-30¥30m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentrevenue2023-04-01 → 2023-06-30¥929m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentrevenue external2023-04-01 → 2023-06-30¥929m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentsegment profit2023-04-01 → 2023-06-30¥170m
—segment totalrevenue2023-04-01 → 2023-06-30¥1.3bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥1.3bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥323,000
—segment totalsegment profit2023-04-01 → 2023-06-30¥200m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥323,000
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥200m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue2022-04-01 → 2022-06-30¥353m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue external2022-04-01 → 2022-06-30¥352m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentsegment profit2022-04-01 → 2022-06-30¥25m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentrevenue2022-04-01 → 2022-06-30¥981m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentrevenue external2022-04-01 → 2022-06-30¥981m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentsegment profit2022-04-01 → 2022-06-30¥199m
—segment totalrevenue2022-04-01 → 2022-06-30¥1.3bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥1.3bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥1m
—segment totalsegment profit2022-04-01 → 2022-06-30¥224m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥1m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥224m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 362
ItemContextValueUnit
Noncurrent liabilitiesPrior1YearInstant2111068000JPY
Noncurrent liabilitiesCurrentQuarterInstant1936341000JPY
LiabilitiesPrior1YearInstant3494583000JPY
LiabilitiesCurrentQuarterInstant3556407000JPY
Capital stockPrior1YearInstant1939834000JPY
Capital stockCurrentQuarterInstant1939834000JPY
Capital surplusPrior1YearInstant518489000JPY
Capital surplusCurrentQuarterInstant518489000JPY
Retained earningsPrior1YearInstant3435330000JPY
Retained earningsCurrentQuarterInstant3483684000JPY
Treasury stockPrior1YearInstant-206244000JPY
Treasury stockCurrentQuarterInstant-203437000JPY
Shareholders equityPrior1YearInstant5687410000JPY
Shareholders equityCurrentQuarterInstant5738571000JPY
Valuation difference on available for sale securitiesPrior1YearInstant51913000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant48593000JPY
Revaluation reserve for landPrior1YearInstant27151000JPY
Revaluation reserve for landCurrentQuarterInstant27151000JPY
Foreign currency translation adjustmentPrior1YearInstant66955000JPY
Foreign currency translation adjustmentCurrentQuarterInstant78434000JPY
Valuation and translation adjustmentsPrior1YearInstant146020000JPY
Valuation and translation adjustmentsCurrentQuarterInstant154179000JPY
Net assetsPrior1YearInstant5833431000JPY
Net assetsCurrentQuarterInstant5892750000JPY
Liabilities and net assetsPrior1YearInstant9328014000JPY
Liabilities and net assetsCurrentQuarterInstant9449158000JPY
Net salesPrior1YTDDuration1333010000JPY
Net salesCurrentYTDDuration1290169000JPY
Cost of salesPrior1YTDDuration859317000JPY
Cost of salesCurrentYTDDuration836842000JPY
Gross profitPrior1YTDDuration473693000JPY
Gross profitCurrentYTDDuration453327000JPY
Selling general and administrative expensesPrior1YTDDuration319249000JPY
Selling general and administrative expensesCurrentYTDDuration334272000JPY
Operating incomePrior1YTDDuration154444000JPY
Operating incomeCurrentYTDDuration119055000JPY
Interest income noiPrior1YTDDuration150000JPY
Interest income noiCurrentYTDDuration106000JPY
Dividends income noiPrior1YTDDuration1668000JPY
Dividends income noiCurrentYTDDuration1597000JPY
Foreign exchange gains noiPrior1YTDDuration24967000JPY
Foreign exchange gains noiCurrentYTDDuration13842000JPY
Other noiPrior1YTDDuration1250000JPY
Other noiCurrentYTDDuration4962000JPY
Non operating incomePrior1YTDDuration28036000JPY
Non operating incomeCurrentYTDDuration20508000JPY
Interest expenses noePrior1YTDDuration3304000JPY
Interest expenses noeCurrentYTDDuration4110000JPY
Other noePrior1YTDDuration1554000JPY
Other noeCurrentYTDDuration130000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass